Alkermes plc Stock
Price
Target price
€22.60
€22.60
0.890%
0.2
0.890%
€34.08
19.07.24 / Stuttgart Stock Exchange
WKN: A1JKVH / Symbol: ALKS / Name: Alkermes / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Alkermes plc Stock
Alkermes plc gained 0.890% compared to yesterday.
We see a rather positive sentiment for Alkermes plc with 14 Buy predictions and 2 Sell predictions.
As a result the target price of 34 € shows a very positive potential of 50.44% compared to the current price of 22.6 € for Alkermes plc.
Pros and Cons of Alkermes plc in the next few years
Pros
?
B****
?
S********** s********
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Alkermes plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Alkermes plc | 0.890% | 4.630% | -2.586% | -20.423% | -9.600% | 11.881% | 9.709% |
| Icon plc | -0.760% | -1.623% | 2.607% | 37.336% | 17.253% | - | - |
| Arrowhead Pharmaceuticals Inc. | 0.550% | 0.892% | 9.053% | -19.766% | -7.599% | -54.889% | -2.910% |
| Ironwood Pharmaceuticals | -3.250% | 0.000% | 6.250% | -37.696% | -41.667% | -46.396% | - |
Comments
Alkermes plc (NASDAQ: ALKS) is now covered by analysts at TD Cowen. They set a "buy" rating and a $34.00 price target on the stock.
Show more
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) had its price target raised by analysts at Cantor Fitzgerald from $43.00 to $48.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) had its price target raised by analysts at Jefferies Financial Group Inc. from $42.00 to $50.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ALKS provided by MarketBeat
